Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
R&D Open science: disrupting scientific community collaboration The quiet rise of collaboration among pharma companies has never been more important.
R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D Allogeneic therapies: The future of cancer treatment? Allogeneic therapies could provide an answer to some of the drawbacks of autologous therapies.
R&D 12 Questions with Ben Wiegand 12 Question with Ben Wiegand: transforming healthcare from disease care to health care.
R&D IWD: Aline Gégout on women in STEM To mark International Women’s Day 2023, we caught up with Aline Gégout of Roche Diabetes Care.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
